Healthcare provider profile · identity verified

Medha Chunduru, MD

Family Practice · BEAVERTON, OR · NPI 1013395086

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1131	411
Levothyroxine Sodium	Levothyroxine Sodium	742	268
Amlodipine Besylate	Amlodipine Besylate	580	212
Losartan Potassium	Losartan Potassium	570	208
Lisinopril	Lisinopril	516	189
Gabapentin	Gabapentin	503	189
Metformin Hcl	Metformin Hcl	445	167
Rosuvastatin Calcium	Rosuvastatin Calcium	430	170
Pantoprazole Sodium	Pantoprazole Sodium	380	143
Simvastatin	Simvastatin	378	136
Albuterol Sulfate Hfa	Albuterol Sulfate	353	134
Metoprolol Succinate	Metoprolol Succinate	350	127
Omeprazole	Omeprazole	324	115
Famotidine	Famotidine	317	115
Montelukast Sodium	Montelukast Sodium	223	74
Furosemide	Furosemide	189	80
Hydrochlorothiazide	Hydrochlorothiazide	183	78
Jardiance	Empagliflozin	183	69
Metoprolol Tartrate	Metoprolol Tartrate	179	61
Tamsulosin Hcl	Tamsulosin Hcl	174	70
Pravastatin Sodium	Pravastatin Sodium	164	63
Glimepiride	Glimepiride	160	51
Fluticasone Propionate	Fluticasone Propionate	157	65
Metformin Hcl Er	Metformin Hcl	155	60
Azithromycin	Azithromycin	142	129
Clopidogrel	Clopidogrel Bisulfate	136	49
Glipizide	Glipizide	124	51
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	43
Tramadol Hcl	Tramadol Hcl	120	55
Januvia	Sitagliptin Phosphate	119	48
Escitalopram Oxalate	Escitalopram Oxalate	118	52
Symbicort	Budesonide/Formoterol Fumarate	117	31
Alendronate Sodium	Alendronate Sodium	115	38
Trazodone Hcl	Trazodone Hcl	115	47
Hydroxyzine Hcl	Hydroxyzine Hcl	114	65
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	109	41
Carvedilol	Carvedilol	104	36
Sertraline Hcl	Sertraline Hcl	102	44
Duloxetine Hcl	Duloxetine Hcl	99	41
Tizanidine Hcl	Tizanidine Hcl	97	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	34
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	92	41
Eliquis	Apixaban	91	32
Ozempic	Semaglutide	91	28
Trulicity	Dulaglutide	87	29
Glipizide Er	Glipizide	86	32
Hydralazine Hcl	Hydralazine Hcl	82	30
Alprazolam	Alprazolam	80	35
Myrbetriq	Mirabegron	80	25
Acetaminophen-Codeine	Acetaminophen With Codeine	74	34
Meloxicam	Meloxicam	74	33
Fenofibrate	Fenofibrate	71	18
Allopurinol	Allopurinol	68	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	65	60
Ezetimibe	Ezetimibe	65	24
Benazepril Hcl	Benazepril Hcl	64	22
Potassium Chloride	Potassium Chloride	62	28
Donepezil Hcl	Donepezil Hcl	61	31
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	60	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	26
Irbesartan	Irbesartan	56	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	56	52
Methylprednisolone	Methylprednisolone	54	52
Mirtazapine	Mirtazapine	54	22
Baclofen	Baclofen	53	24
Glipizide-Metformin	Glipizide/Metformin Hcl	53	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	42
Janumet	Sitagliptin Phos/Metformin Hcl	51	11
Vitamin D2	Ergocalciferol (Vitamin D2)	50	31
Buspirone Hcl	Buspirone Hcl	48	28
Doxycycline Monohydrate	Doxycycline Monohydrate	46	43
Celecoxib	Celecoxib	45	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	40
Mounjaro	Tirzepatide	45	14
Esomeprazole Magnesium	Esomeprazole Magnesium	44	16
Paxlovid	Nirmatrelvir/Ritonavir	44	44
Quetiapine Fumarate	Quetiapine Fumarate	44	17
Clonidine Hcl	Clonidine Hcl	42	16
Olmesartan Medoxomil	Olmesartan Medoxomil	42	15
Oxybutynin Chloride	Oxybutynin Chloride	42	19
Insulin Lispro Kwikpen U-100	Insulin Lispro	41	15
Pioglitazone Hcl	Pioglitazone Hcl	40	17
Farxiga	Dapagliflozin Propanediol	39	18
Diclofenac Sodium	Diclofenac Sodium	38	17
Meclizine Hcl	Meclizine Hcl	38	23
Atenolol	Atenolol	36	12
Incontrol Pen Needle	Pen Needle, Diabetic	36	18
Prednisone	Prednisone	36	26
Ibuprofen	Ibuprofen	35	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	23
Nitroglycerin	Nitroglycerin	31	14
Spironolactone	Spironolactone	31	11
Clonazepam	Clonazepam	30	14
Finasteride	Finasteride	30	11
Pregabalin	Pregabalin	30	15
Citalopram Hbr	Citalopram Hydrobromide	29	11
Lidocaine	Lidocaine	29	15
Propranolol Hcl	Propranolol Hcl	29	suppressed
Valsartan	Valsartan	29	suppressed
Fluconazole	Fluconazole	28	22
Levetiracetam	Levetiracetam	27	12
Bydureon Bcise	Exenatide Microspheres	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Clotrimazole	Clotrimazole	23	18
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Lactulose	Lactulose	22	16
Naproxen	Naproxen	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	12
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Folic Acid	Folic Acid	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Cephalexin	Cephalexin	20	16
Ondansetron Hcl	Ondansetron Hcl	20	16
Ondansetron Odt	Ondansetron	19	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Valacyclovir	Valacyclovir Hcl	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	16	14
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ramipril	Ramipril	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Digoxin	Digoxin	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Temazepam	Temazepam	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error